Skip to Main Content


Led by Dr. Michael Cleman, Professor of Medicine and Director of the Cardiac Catheterization Laboratory, the Interventional Cardiology service provides state of the art facilities for a full spectrum of coronary, structural heart disease, peripheral interventions, and invasive diagnostic studies. 

Areas of interest including complex coronary angioplasty, structural heart disease including percutaneous aortic valve replacement (TAVR), and peripheral vascular disease, including one of the largest carotid programs in New England. The interventional cardiology faculty are involved in a wide range of trails evaluating novel therapeutic options including bioabsobable stents, transcatheter devices for aortic valve replacement and mitral repair, and drug-eluting balloon therapies for peripheral vascular disease and critical limb ischemia.

Visit our website to learn more about the Interventional Cardiology Program

Yale Interventional Cardiology has a robust history in cardiovascular catheterization and intervention providing state of the art care for patients in the New England and New York Regions and currently serves as a national and international referral center for specialty percutaneous interventional procedures. The Yale Interventional team services Yale New Haven Hospital, the West Haven Veterans Affairs Medical Center, Greenwich Hospital, Lawrence and Memorial Hospital, and Backus Hospitals in the Connecticut community.

Yale Interventional cardiology is focused on global vascular patient care with specialists in complex coronary disease, structural heart disease, and peripheral vascular diseases. We both lead and participate in a variety of clinical trials to develop devices and techniques to manage unmet needs in interventional cardiovascular medicine. Our research team is engaged in clinical investigation locally and also has global reach via our investigational team, infrastructure, and core laboratories with Yale Cardiovascular Research Group (YCRG). We have developed international affiliations with University College London in the UK, and Clinica Cardiovid in Columbia, South America, which has provided synergies in clinical medicine, research, and education. In addition we are in the process of establishing a similar affiliation with the University of Athens Medical School. 

The overall goal of these programs is to provide a framework to enhance research and development by providing an infrastructure and network for “vertical device development”, e.g. bench to regulatory approval and patient care.

From the early history of interventional cardiology at Yale with among the world’s first applications of rotational atherectomy, coronary stents, and brachytherapy to the current era of advanced coronary revascularization, transcatheter valve repair and replacement, structural interventions, and global endovacular patient care, the interventional team is excited to live in a fun, innovative, and interesting time at Yale.